Clinical Trial Update: Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist

View source ↗

Summary

Completed real-world study comparing dabigatran etexilate-based therapy to vitamin K antagonists in patients with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Pradaxa (dabigatran etexilate)
• Warfarin (warfarin)

Snippet

Sponsor: Bayer | Conditions: Atrial Fibrillation | Status: COMPLETED